» Articles » PMID: 39639868

Exploring the Shared Pathogenic Mechanisms of Tuberculosis and COVID-19: Emphasizing the Role of VNN1 in Severe COVID-19

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In recent years, COVID-19 and tuberculosis have emerged as major infectious diseases, significantly contributing to global mortality as respiratory illnesses. There is increasing evidence of a reciprocal influence between these diseases, exacerbating their incidence, severity, and mortality rates.

Methods: This study involved retrieving COVID-19 and tuberculosis data from the GEO database and identifying common differentially expressed genes. Machine learning techniques, specifically random forest analysis, were applied to pinpoint key genes for diagnosing COVID-19. The Cibersort algorithm was employed to estimate immune cell infiltration in individuals with COVID-19. Additionally, single-cell sequencing was used to study the distribution of VNN1 within immune cells, and molecular docking provided insights into potential drugs targeting these critical prognosis genes.

Results: GMNN, SCD, and FUT7 were identified as robust diagnostic markers for COVID-19 across training and validation datasets. Importantly, VNN1 was associated with the progression of severe COVID-19, showing a strong correlation with clinical indicators and immune cell infiltration. Single-cell sequencing demonstrated a predominant distribution of VNN1 in neutrophils, and molecular docking highlighted potential pharmacological targets for VNN1.

Conclusions: This study enhances our understanding of the shared pathogenic mechanisms underlying tuberculosis and COVID-19, providing essential insights that could improve the diagnosis and treatment of severe COVID-19 cases.

References
1.
Hosseini A, Hashemi V, Shomali N, Asghari F, Gharibi T, Akbari M . Innate and adaptive immune responses against coronavirus. Biomed Pharmacother. 2020; 132:110859. PMC: 7580677. DOI: 10.1016/j.biopha.2020.110859. View

2.
Wang Z, Yang B, Li Q, Wen L, Zhang R . Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020; 71(15):769-777. PMC: 7184452. DOI: 10.1093/cid/ciaa272. View

3.
Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Deng Y . Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis. 2020; 96:131-135. PMC: 7196544. DOI: 10.1016/j.ijid.2020.04.086. View

4.
Sohrabi C, Alsafi Z, ONeill N, Khan M, Kerwan A, Al-Jabir A . World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020; 76:71-76. PMC: 7105032. DOI: 10.1016/j.ijsu.2020.02.034. View

5.
Kindler E, Thiel V, Weber F . Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response. Adv Virus Res. 2016; 96:219-243. PMC: 7112302. DOI: 10.1016/bs.aivir.2016.08.006. View